目的 探讨Ki-67、微小染色体维持蛋白2(MCM2)、p16在宫颈鳞状上皮内病变中的表达及其临床意义。方法 采用免疫组化检测Ki-67、MCM2、p16在宫颈炎症组14例、低级别鳞状上皮内病变(LSIL)组47例、高级别鳞状上皮内病变(HSIL)组49例中的表达情况,以病理结果作为金标准,对结果进行统计分析。结果 HSIL组中Ki-67、MCM2、p16阳性率均高于炎症组和LSIL组(均P<0.017)。HSIL组中Ki-67、MCM2过表达率均显著高于炎症组和LSIL组(均P<0.017)。随着宫颈病变级别增加,Ki-67及MCM2阳性范围从基底层至表层逐渐扩大。MCM2及Ki-67在LSIL组中表达模式多为基底层的非过表达模式,HSIL组多为中层及以上的过表达模式。Spearman相关性分析显示,MCM2和Ki-67在宫颈鳞状上皮内病变中的表达强度之间呈正相关(r=0.801,P<0.05);p16与MCM2在宫颈鳞状上皮内病变中的表达呈正相关(r=0.559,P<0.05);p16与Ki-67在宫颈鳞状上皮内病变中的表达呈正相关(r=0.478,P<0.05)。结论 p16阳性提示宫颈高级别鳞状上皮内病变。MCM2与Ki-67在宫颈鳞状上皮内病变中的表达具有较高一致性,MCM2可作为宫颈鳞状上皮内病变新的增殖标志物。
Objective To investigate the expression and significance of Ki-67,MCM2 and p16 in cervical intraepithelial lesions.Methods The expressions of Ki-67,MCM2 and p16 in cervicitis group(14 cases),low-grade squamous intraepithelial lesion(LSIL) group(47 cases)and high-grade squamous intraepithelial lesion(HSIL) group(49 cases)were detected by immunohistochemistry.The pathological results were used as the gold standard for statistical analysis.Results The positive rates of Ki-67,MCM2 and p16 in HSIL group were significantly higher than those in cervicitis group and LSIL group(P<0.017).The over-expression rates of Ki-67,MCM2 in HSIL group were significantly higher than those in cervicitis group and LSIL group(P<0.017).With the increase of cervical lesion grade,the positive range of Ki-67 and MCM2 gradually expanded from basal layer to surface layer.The expression patterns of MCM2 and Ki-67 in LSIL group were mostly non-overexpressed in the basal layers,while those in HSIL group were mostly overexpressed in the middle layer and above.Spearman correlation analysis showed that the expression intensity of MCM2 and Ki-67 in cervical squamous intraepithelial lesions was positively correlated(r=0.801,P<0.05).There was a positive correlation between the expression of p16 and MCM2 in cervical squamous intraepithelial lesions(r=0.559,P<0.05).There was a positive correlation between the expression of p16 and Ki-67 in cervical squamous intraepithelial lesions(r=0.478,P<0.05).Conclusions Positive p16 indicates high-grade squamous intraepithelial lesion.The expression of MCM2 and Ki-67 in cervical intraepithelial lesions is highly consistent.MCM2 can be used as a new proliferative marker for cervical intraepithelial lesions.
目的 评估CO2激光治疗宫颈上皮内瘤变Ⅱ级(CIN2)病例的疗效。方法 收集2021年11月至2023年10月在本院行CO2激光治疗的92例CIN2患者的临床资料, 采用液基细胞学检查(LCT)和人乳头状瘤病毒(HPV)联合筛查随访,随访6~12个月, 任一结果异常者转诊阴道镜检查, 必要时行病理活组织检查(活检)观察鳞状上皮内病变情况。结果 92例CIN2患者中, 年龄25~45岁、有人工流产史、性伴侣人数3个及以上、因发现宫颈病变就诊者占比较多,患者均未生育。所有患者就诊时均发现HPV阳性, 20.65%患者报告HPV16阳性, HPV18阳性者占比1.09%, HPV其他12种阳性占60.87%, HPV16阳性伴其他12种阳性占17.39%。79例患者随访6个月后总HPV+LCT均阴率为74.68%(59/79),LCT和HPV阴转率分别为92.41%(73/79)和74.68%(59/79)。所有患者术后12个月LCT均转阴。29例患者在术后12个月均无病变持续或病变发展。25岁以下患者术后6个月及12个月HPV持续率最低, 45~55岁患者术后HPV持续率最高,且多发生HPV16阳性及合并其他HPV亚型阳性的情况。结论 CO2激光治疗可提高患者术后HPV与LCT阴转率, 所有患者术后6个月及12个月随访均无病变加重,且可明显改善年轻患者HPV感染情况。对于有生育要求且具备适应证的CIN2患者, 应积极采取CO2激光治疗以获得更高健康收益。
Objective To evaluate the therapeutic efficacy of CO2 laser treatment in cervical intraepithelial neoplasia grade 2(CIN2)patients. Methods We retrospectively analyzed data from 92 CIN2 patients who underwent CO2 laser therapy at the institution from November 2021 to October 2023. Postoperative followed-up for 6-12 months, screening with liquid-based cytopathology test(LCT)and high-risk human papilloma virus(HPV)testing. Patients with abnormal results in either test were referred for colposcopy, with biopsy performed to evaluate residual or recurrent squamous intraepithelial lesions. Results Among total of 92 patients, most patients aged 25-45 years old, with a history of induced abortion, had three or more sexual partners, and visited hospital due to cervical lesions, and none of the patients gave birth. All patients were found to be HPV positive at hospital visits, with 20. 65% of HPV16 positive, 1. 09% of HPV18 positive, 60. 87% of other 12 kinds HPV positive, while HPV16 positive with other 12 kinds accounted for 17. 39%. Among the 79 patients after 6-month follow-up, the dual-negative conversion rate(HPV+LCT)was 74. 68%(59/79), with LCT and HPV negative rates reaching 92. 41%(73/79)and 74. 68%(59/79), respectively. After 12-month follow-up, all patients achieved LCT negativity, 29 patients with no documented lesion persistence or disease progression. Notably, patients aged <25 years exhibited the lowest postoperative HPV persistence rates between 6- to 12-month follow-up, whereas those aged 45-55 years demonstrated the highest persistence rates, frequently associated with HPV16 positivity or co-infection with other HPV subtypes. Conclusions CO2 laser therapy significantly increases postoperative negative conversion rates for HPV and LCT. No lesion progression was observed in patients between 6- to 12-month follow-ups. The therapy also notably improves HPV clearance in younger patients. For patients with CIN2 who have fertility requirements and meet the indications, CO2 laser therapy should be actively adopted to achieve greater health benefits.
目的 探讨Ki-67、微小染色体维持蛋白2(MCM2)、p16在宫颈鳞状上皮内病变中的表达及其临床意义。方法 采用免疫组化检测Ki-67、MCM2、p16在宫颈炎症组14例、低级别鳞状上皮内病变(LSIL)组47例、高级别鳞状上皮内病变(HSIL)组49例中的表达情况,以病理结果作为金标准,对结果进行统计分析。结果 HSIL组中Ki-67、MCM2、p16阳性率均高于炎症组和LSIL组(均P<0.017)。HSIL组中Ki-67、MCM2过表达率均显著高于炎症组和LSIL组(均P<0.017)。随着宫颈病变级别增加,Ki-67及MCM2阳性范围从基底层至表层逐渐扩大。MCM2及Ki-67在LSIL组中表达模式多为基底层的非过表达模式,HSIL组多为中层及以上的过表达模式。Spearman相关性分析显示,MCM2和Ki-67在宫颈鳞状上皮内病变中的表达强度之间呈正相关(r=0.801,P<0.05);p16与MCM2在宫颈鳞状上皮内病变中的表达呈正相关(r=0.559,P<0.05);p16与Ki-67在宫颈鳞状上皮内病变中的表达呈正相关(r=0.478,P<0.05)。结论 p16阳性提示宫颈高级别鳞状上皮内病变。MCM2与Ki-67在宫颈鳞状上皮内病变中的表达具有较高一致性,MCM2可作为宫颈鳞状上皮内病变新的增殖标志物。
Objective To investigate the expression and significance of Ki-67,MCM2 and p16 in cervical intraepithelial lesions.Methods The expressions of Ki-67,MCM2 and p16 in cervicitis group(14 cases),low-grade squamous intraepithelial lesion(LSIL) group(47 cases)and high-grade squamous intraepithelial lesion(HSIL) group(49 cases)were detected by immunohistochemistry.The pathological results were used as the gold standard for statistical analysis.Results The positive rates of Ki-67,MCM2 and p16 in HSIL group were significantly higher than those in cervicitis group and LSIL group(P<0.017).The over-expression rates of Ki-67,MCM2 in HSIL group were significantly higher than those in cervicitis group and LSIL grou(P<0.017).With the increase of cervical lesion grade,the positive range of Ki-67 and MCM2 gradually expanded from basallayer to surface layer.The expression patterns of MCM2 and Ki-67 in LSIL group were mostly non-overexpressed in the basal layers,while those in HSIL group were mostly overexpressed in the middle layer and above.Spearman correlation analysis showed that the expression intensity of MCM2 and Ki-67 in cervical squamous intraepithelial lesions was positively correlated(r=0.801,P<0.05).There was a positive correlation between the expression of p16 and MCM2 in cervical squamous intraepithelial lesions(r=0.559,P<0.05).There was a positive correlation between the expression of p16 and Ki-67 in cervical squamous intraepithelial lesions(r=0.478,P<0.05).Conclusions Positive p16 indicates high-grade squamous intraepithelial lesion.The expression of MCM2 and Ki-67 in cervical intraepithelial lesions is highly consistent.MCM2 can be used as a new proliferative marker for cervical intraepithelial lesions.